ABSTRACT. Sunscreens block the cutaneous absorption of UV-B radiation and prevent sunburning, premature aging, and cancer of the skin. Inasmuch as UV-B radiation is also responsible for the photosynthesis of vitamin D 3 , we investigated the effect of sunscreens on the cutaneous formation of vitamin D 3 in vivo and in vitro. Eight normal subjects, four of whom had been protected with the sunscreen pctra-aminobenzoic acid (sun protection factor 8), were exposed to one minimal erythema dose of UV radiation. The mean serum vitamin D 3 concentration increased from 1.5 ± 1.0 (±SEM) to 25.6 ± 6.7 ng/mL in unprotected subjects, whereas it was 5.6 ± 3.0 and 4.4 ± 2.4 ng/mL at these times in the subjects who were protected with para-aminobenzoic acid. Pora-aminobenzoic acid also prevented the photoisomerization of 7-dehydrocholesterol to previtamin D 3 in human skin slices in vitro. These results indicate that the sunscreen interferred with the cutaneous production of vitamin D 3 . (J Clin Endocrinol Metab 64: 1165, 1987 A VARIETY of biological effects occur in human skin after exposure to sunlight. Of particular concern are the photochemical reactions triggered by the high energy wavelengths 290-320 nm (UV-B). Acute exposure (minutes to hours) to solar UV irradiation (UVR) causes erythema, whereas chronic exposure (years to decades) produces cancer and premature aging of the skin (1, 2). These adverse effects of sunlight can be prevented by the routine topical use of sunscreening agents, such as para-aminobenzoic acid (PABA), esters of para-aminobenzoic acid, cinnamates, and salicylates (3). Topical sunscreens absorb UV-B radiation, thereby interfering with the penetration of solar radiation to the skin.
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Exposure to solar UVR also promotes vitamin D 3 synthesis in the skin (4). After solar irradiation, the UV-B photons absorbed by the epidermis cause the sterol 7-dehydroxycholesterol to be photolysed to previtamin D 3 (4) (5) (6) . This thermally labile photoproduct spontaneously isomerizes over several days to vitamin D3 (4), which enters the circulation. Vitamin D-binding protein may help translocate vitamin D 3 into the circulation (4) . Once in the circulation, vitamin D 3 is metabolized sequentially in the liver and kidney to its biologically active form, 1,25-dihydroxyvitamin D 3 (5) .
Because sunscreens act by absorbing high energy solar UVR, we investigated the effect of topical application of PABA on the photosynthesis of previtamin D 3 in human skin in vitro. We also determined the effect of a sunscreening agent on the circulating vitamin D concentrations in normal subjects exposed to whole body UV radiation.
Materials and Methods

In vitro studies
A piece of normal human skin that had been surgically removed during a reduction mammoplasty from a woman was obtained from the Department of Pathology and divided into nine pieces (each 6.2 cm 2 ). Triplicate samples of skin received an application of either 0.1 mL ethanol or ethanol with 5% (wt/vol) PABA. These six skin specimens were then exposed to 1 MED (~30 mjoules/cm 2 ) of simulated solar UVR, as previously described (6) . The three remaining pieces of skin served as controls. All skin samples were then separated into dermis and epidermis (6) . The basal layer of the epidermis was further isolated, using techniques previously described in detail (4) . The lipid fraction of the basal layer was extracted in 8% ethyl acetate in n-hexane, and the 7-dehydrocholesterol and previtamin D 3 were separated and quantitated by high performance liquid chromatography (HPLC) (4) (5) (6) .
In vivo studies
Effect of a single application of PABA on serum vitamin D concentrations. The study population was comprised of eight normal subjects (six women and two men), all Caucasian, ranging in age from 21-45 yr. The study was performed during a 1166 MATSUOKA ET Ah.
Vol 64 • No 6 period of 21 days in early spring (April through May), The participants were asked to avoid direct exposure to sunlight during the experiment. All had normal hepatic and renal function, and none was taking vitamin D, anticonvulsant drugs, or steroids. Each gave written informed consent, and the study was approved by the Springfield Committee for Research on Human Subjects. UVR was delivered in a walk-in irradiation chamber (National Biological Corp., Cleveland, OH) equipped with eight vertically arranged fluorescent sunlamps (Westinghouse model FS72T12, Bloomfield, NJ). The total spectral distribution ranged from 260-360 nm, with a peak emission at 313 nm; the energy delivered by the wavelengths in the band 260-330 nm was 0.8 mwatts, determined at a distance 30 cm from the source.
The minimal erythema dose (MED) for each subject was determined 1 week before the study. Five test areas of 1 cm 2 each on the skin of the lower aspect of the back were left unprotected and were successively exposed to UVR for variable periods. The lowest dose was one third of the estimated MED, with subsequent stepwise increments of 40% for the other squares. Twenty-four hours later, the exposed sites were examined, and the lowest dose of UVR that caused a faint pink coloration with four distinct borders was recorded as the MED for that individual.
Each subject was then randomly assigned to one of the two study groups. Four subjects received whole body exposure to 1 MED UVR. The other four subjects received a total body application of approximately 10 mL 5% PABA in 55% ethanol with water and emollients (PreSun, Westwood Pharmaceuticals, Buffalo, NY; sun protection-factor 8) 1. h before whole body exposure to 1 MED UVR. Blood samples were obtained 24 and 2 h before the total body exposure to UVR and 1, 2, 3, 7, and 14 days after the exposure. Serum was separated and stored at -20 C until the time of analysis for vitamin D (7-9).
Experimental methods
Serum vitamin D 3 concentrations were determined as previously described (9) . Serum samples (3-4 mL) were extracted with methanol-methylene chloride. The lipid extracts then were subjected to preparative chromatography on silica Sep-Pak cartridges (Waters Associates, Milford, MA) for the initial separation of vitamin D from 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and other vitamin D-hydroxylated metabolites (9) . The fraction containing vitamin D was further purified by a modified two-stage HPLC procedure (8, 10) . The initial step consisted of reverse phase HPLC, in which the samples were chromatographed on a Radial-Pak A column (Waters Associates) and eluted with a solution of 2% water in methanol at a constant flow rate of 2 mL/min. Final purification was performed by straight phase HPLC on a Zorbax-sil column (25 cm X 6.2 mm; DuPont Instruments, Wilmington, DE) with 3% isopropranol in n-hexane as the eluant at a flow rate of 1.5 mL/min. Vitamin D was quantitated by UV absorbance at 254 nm (Waters model 440 UVR detector) (8, 10). The lower limit of detection for this method was 0.5 ng/mL. To test the relative contribution of vitamin D 2 to the total vitamin D concentration, serum samples were analyzed by reverse phase HPLC (8, 9); they were found to contain only vitamin D 3 . The overall recovery of tritiated vitamin D 3 through the extraction and purification procedures was 45 ± 3% (mean ±SEM), which was used in the calculations for determining the serum concentrations of vitamin D. The interassay coefficient of variation was 12%.
Statistical methods
Statistical significance was determined by analysis of variance (11), considering seven time points (-1, 0, 1, 2, 3, 7, and 14 days) in the two groups of patients (PABA-treated and PABA-untreated).
Results
Comparison of UV absorption spectrum of PABA with the action spectrum for previtamin D 3 photosynthesis in human epidermis revealed marked overlap (Fig. 1) . PABA absorbs the radiation between 240 and 400 nm and overlaps the spectrum responsible for the photosynthesis of previtamin D 3 (radiation between 260-315 nm [6] ).
Exposure of triplicate samples of human skin to simulated solar radiation resulted in the conversion of 15 ± 2% of the 7-dehydrocholesterol stores in the stratum basale to previtamin D 3 (Fig. 2B ). This photochemical reaction was completely blocked by topical application of PABA immediately before exposure to the same amount of simulated solar radiation. Previtamin D 3 was not detected in the stratum basale of any of the PABAtreated skin samples or the skin samples not exposed to simulated solar radiation (Fig. 2, A and C) .
PABA had a significant effect on the cutaneous synthesis of vitamin D in vivo. Exposure to 1 MED UVR in subjects receiving PABA vehicle alone produced a marked and significant (P < 0.01) increase in mean 
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FlG. 2. Chromatograms of vitamin D 3 precursors in lipid extracts of stratum basale from human skin. Specimen A was untreated skin; specimen B received a topical application of vehicle (ethanol) solution before UV-B irradiation; specimen C received a topical application of PABA in ethanol before UV-B irradiation. PABA blocked the photoisomerization of 7-dehydrocholesterol (7-DHC) to previtamin D 3 . serum vitamin D 3 concentrations, from 1.5 ± 1.0 ng/mL on day 0 to a peak of 25.6 ± 6.7 ng/mL on day 1 after the exposure (Fig. 3) . In contrast, serum vitamin D3 concentrations did not change in the subjects who had applied PABA 1 h before exposure to UVR. They were 5.6 ± 3.0 ng/mL on day 0 and 4.4 ± 2.4 ng/mL on day 1.
Discussion
These results demonstrate that a single topical application of PABA, the active principle in many sunscreens, interferes significantly with the cutaneous synthesis of vitamin D 3 . We found that PABA blocked the photosynthesis of previtamin D 3 in the human epidermis and that the elevation in serum vitamin D 3 concentrations exposed to the equivalent of 1 MED UVR was prevented by a sunscreen containing PABA.
Chronic exposure to sunlight is thought to be an important predisposing factor for skin cancer among Caucasians and has been associated with premature aging of the skin (12) . Sunscreens used for preventing sunburning during acute exposures to the sun also are advocated for the prevention of skin cancer recurrences and other chronic effects of solar irradiation (1, 13) . However, the high energy UVR responsible for causing erythema, photoaging, and skin cancer is the same radiation responsible for the promotion of vitamin D 3 synthesis in the skin (6) .
The effect of topical sunscreening agents to limit or prevent the cutaneous production of vitamin D 3 is probably of little consequence for children and young adults, who obtain adequate vitamin D nutrition from their diet and frequent exposure to sunlight. However, the elderly, who are more prone to developing vitamin D deficiency (14) (15) (16) (17) , often rely on exposure to the sun as their major if not sole source of vitamin D (18, 19) . These individuals could significantly increase their risk of vitamin D deficiency if they consistently apply a sunscreen before going outdoors. To balance the concern about the harmful effects of sunlight with the beneficial effect on vitamin D nutrition, susceptible individuals may omit sunscreening agents and expose their skin only to suberythemal doses of sunlight. In the case of prolonged outdoor activities, a topical sunscreen may be applied immediately after the initial exposure.
In conclusion, sunscreening agents cause a defect in the cutaneous synthesis of vitamin D 3 . We suggest that elderly chronic users of these substances should be routinely investigated for vitamin D deficiency.
